KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Liabilities and Shareholders Equity (2016 - 2026)

Abbott Laboratories' Liabilities and Shareholders Equity history spans 18 years, with the latest figure at $110.4 billion for Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 35.58% to $110.4 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $365.3 billion, a 17.76% increase, with the full-year FY2025 number at $86.7 billion, up 6.51% from a year prior.
  • Liabilities and Shareholders Equity hit $110.4 billion in Q1 2026 for Abbott Laboratories, up from $86.7 billion in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for ABT hit a ceiling of $110.4 billion in Q1 2026 and a floor of $2.9 billion in Q4 2022.
  • Historically, Liabilities and Shareholders Equity has averaged $74.4 billion across 5 years, with a median of $74.0 billion in 2022.
  • Biggest five-year swings in Liabilities and Shareholders Equity: crashed 60.29% in 2022 and later soared 2439.51% in 2023.
  • Tracing ABT's Liabilities and Shareholders Equity over 5 years: stood at $2.9 billion in 2022, then soared by 2439.51% to $73.2 billion in 2023, then grew by 11.2% to $81.4 billion in 2024, then grew by 6.51% to $86.7 billion in 2025, then rose by 27.35% to $110.4 billion in 2026.
  • Business Quant data shows Liabilities and Shareholders Equity for ABT at $110.4 billion in Q1 2026, $86.7 billion in Q4 2025, and $84.2 billion in Q3 2025.